These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33358270)

  • 1. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.
    El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.
    El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs.
    El Mansouri AE; Maatallah M; Ait Benhassou H; Moumen A; Mehdi A; Snoeck R; Andrei G; Zahouily M; Lazrek HB
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(8):1088-1107. PubMed ID: 32397827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase.
    Dhanalakshmi B; Anil Kumar BM; Srinivasa Murthy V; Srinivasa SM; Vivek HK; Sennappan M; Rangappa S
    J Biomol Struct Dyn; 2024 Jul; 42(11):5841-5857. PubMed ID: 37529915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
    Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
    Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
    Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety.
    Ragab FAF; Abou-Seri SM; Abdel-Aziz SA; Alfayomy AM; Aboelmagd M
    Eur J Med Chem; 2017 Sep; 138():140-151. PubMed ID: 28667871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
    Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents.
    Lakshmithendral K; Saravanan K; Elancheran R; Archana K; Manikandan N; Arjun HA; Ramanathan M; Lokanath NK; Kabilan S
    Eur J Med Chem; 2019 Apr; 168():1-10. PubMed ID: 30798049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
    Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
    Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.
    Abdel-Aziz M; Metwally KA; Gamal-Eldeen AM; Aly OM
    Anticancer Agents Med Chem; 2015; 16(2):269-77. PubMed ID: 26343141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
    Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
    Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis and Evaluation of Novel Substituted (5-methyl-1H-pyrazol-3-yl)- 1,3,4-oxadiazole as Potent Androgen Receptor Antagonist.
    Andavar S; Vaithilingam M; Selvaraj D; Kumaran AA; Devanathan K
    Anticancer Agents Med Chem; 2020; 20(1):84-93. PubMed ID: 31755396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles.
    Mokenapelli S; Thalari G; Vadiyaala N; Yerrabelli JR; Irlapati VK; Gorityala N; Sagurthi SR; Chitneni PR
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000006. PubMed ID: 32309890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA; Nour MS; Salem MA; Arafa RK
    Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and cytotoxicity screening of 5-aryl-3-(2-(pyrrolyl) thiophenyl)-1, 2, 4-oxadiazoles as potential antitumor molecules on breast cancer MCF-7 cells.
    Abd El Hameid MK; Mohammed MR
    Bioorg Chem; 2019 May; 86():609-623. PubMed ID: 30807934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.
    Pidugu VR; Yarla NS; Pedada SR; Kalle AM; Satya AK
    Bioorg Med Chem; 2016 Nov; 24(21):5611-5617. PubMed ID: 27665180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha.
    Kaur K; Verma H; Gangwar P; Jangid K; Dhiman M; Kumar V; Jaitak V
    Bioorg Chem; 2024 Jun; 147():107341. PubMed ID: 38593531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
    Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Molecular Docking Study, and Cytotoxic Activity of 3,4-diaryl-5-(4-pyridinyl)-1,2,4-oxadiazole.
    Zareian B; Ghadbeighi S; Amirhamzeh A; Ostad SN; Shafiee A; Amini M
    Med Chem; 2016; 12(4):394-401. PubMed ID: 26558375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.